Source: International Congress 2016 – Long-term outcomes of lung transplantation



Rating:

Share or cite this content

Citations should be made in the following way:
Ji-Eun Park (Seoul, Republic of Korea), Ji-Eun Park, Eun Hye Lee, Jisoo Choi, Mi Hwa Shin, Song Yee Kim, Young Sam Kim, Se Kyu Kim, Joon Chang, Hyo-Chae Paik, Moo Suk Park. Prevalence of pre-transplant anti-HLA antibodies and their impact on outcomes in lung transplant recipients. Eur Respir J 2016; 48: Suppl. 60, 2553

Member's Comments

No comment yet.

Related content which might interest you: The impact of pre-transplant donor specific anti-HLA antibodies (DSAs) on lung transplant outcome: A single center experience Source: International Congress 2019 – Lung transplantation: from bench to bedside Year: 2019 Role of C1q-binding anti-HLA antibodies as a predictor of lung allograft outcome Source: Eur Respir J, 52 (2) 1701898; 10.1183/13993003.01898-2017 Year: 2018 A virtual crossmatch-based strategy for perioperative desensitisation in lung transplant recipients with pre-formed donor-specific antibodies: 3-year outcome Source: Eur Respir J, 58 (5) 2004090; 10.1183/13993003.04090-2020 Year: 2021 Intragraft donor-specific anti-HLA antibodies in phenotypes of chronic lung allograft dysfunction Source: Eur Respir J, 54 (5) 1900847; 10.1183/13993003.00847-2019 Year: 2019 Donor-specific and -nonspecific HLA antibodies and outcome post lung transplantation Source: Eur Respir J, 50 (5) 1701248; 10.1183/13993003.01248-2017 Year: 2017 Pre-transplant soluble CD30 is a stronger predictor of BOS than anti-HLA antibodies occurring after lung transplantation Source: Annual Congress 2007 - New insights into clinical lung transplantation Year: 2007 CMV management in lung transplant recipients Source: School Course 2012 - Lung Transplantation Year: 2012 Prevalence of SDB in lung transplant recipients Source: Breathe 2010; 6: 274 Year: 2010 Prevalence and outcomes of diabetes in lung transplant recipients: the portuguese experience Source: Virtual Congress 2020 – Clinical management of lung transplant recipients Year: 2020 The outcomes of lung transplantation in patients with bronchiectasis and antibody deficiency Source: Eur Respir J 2004; 24: Suppl. 48, 178s Year: 2004 Intragraft donor-specific antibodies and lung transplantation Source: Eur Respir J, 54 (5) 1901937; 10.1183/13993003.01937-2019 Year: 2019 Aspergillus infections in lung transplant recipients. Risk factors and outcome Source: Eur Respir J 2004; 24: Suppl. 48, 178s Year: 2004 Positive impact of tacrolimus-based immunosuppression after lung transplantation – an analysis of potential risk factors for long-term survival Source: Annual Congress 2007 - New insights into clinical lung transplantation Year: 2007 Short and mid-term outcomes of lung transplant recipients with COVID-19 Source: Virtual Congress 2021 – Challenging problems in lung transplantation Year: 2021 Longitudinal assessment of CD4+CD25highCD69- treg cells in a cohort of lung transplant recipients (LTR). An association with chronic graft rejection Source: Annual Congress 2008 - Donor organs and complications after lung transplantation Year: 2008 Increased LIR-1 expression precedes serum cytomegalovirus detection and diagnosis of CMV disease in lung transplant recipients Source: Eur Respir J 2002; 20: Suppl. 38, 347s Year: 2002 T-cell response against tuberculosis antigens is dependent on the level of immunosuppression in renal and lung transplant patients Source: Eur Respir J 2006; 28: Suppl. 50, 344s Year: 2006 Significance of anti-HLA immunization in lung transplantation Source: Annual Congress 2011 - Immunobiology in the transplanted lung: experimental and clinical evaluations Year: 2011 Fatigue and functional capacity in kidney transplant recipients before and after transplant. Source: International Congress 2017 – Assessing functional outcomes in respiratory physiotherapy Year: 2017 Tuberculosis infection in renal transplant recipients and evaluation of risk factors.> Source: Virtual Congress 2020 – Tuberculosis and society Year: 2020